COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab

被引：0
|
作者：
Sufana Shikdar
Azra Borogovac
Elabdallah Mohamad
Mohamad Khawandanah
机构：
[1] University of Oklahoma Health Sciences Center,Department of Hematology/Oncology, Stephenson Cancer Center
[2] University of Oklahoma Medical Center (OUMC),Department of Internal Medicine
[3] University of Oklahoma Health Sciences Center,Hematology/Oncology fellow, Department of Medicine, Division of Hematology
来源：
Thrombosis Journal | / 19卷
关键词：
COVID19; Paroxysmal nocturnal hemoglobinuria; Complement inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] CONSIDERATIONS ON PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): DIAGNOSIS AND TREATMENT
    Araujo, Franciele Cristina
    da Silva, Jacineide Maria
    de Jesus, Jociel Honorato
    Gomes Geron, Vera Lucia Matias
    Oliveira Lima, Regiane Rossi
    REVISTA CIENTIFICA DA FACULDADE DE EDUCACAO E MEIO AMBIENTE, 2019, 10 (01): : 54 - 61
  • [12] Cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab maintenance treatment
    Moriyama, Mitsuru
    Aota, Yasuo
    Okabe, Masahiro
    Osaka, Yoshiaki
    Katagiri, Seiichiro
    Akahane, Daigo
    Gotoh, Akihiko
    EJHAEM, 2022, 3 (01): : 203 - 206
  • [13] PHARMACOECONOMIC PROSPECTS FOR THE USE OF RAVULIZUMAB IN THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Kolbin, A.
    Velum, I
    Balykina, Y.
    Proskurin, M.
    VALUE IN HEALTH, 2020, 23 : S694 - S694
  • [14] Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria
    Yoo, Justin J.
    Chonat, Satheesh
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (05) : 385 - 392
  • [15] Management of paroxysmal nocturnal hemoglobinuria (PNH)
    Luzzatto, Lucio
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (12)
  • [16] COVID-19 infection presenting as paroxysmal nocturnal hemoglobinuria
    Hines, Adam
    Hakim, Nausheen
    Barrientos, Jacqueline
    CLINICAL CASE REPORTS, 2021, 9 (08):
  • [17] Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy
    Genthon, Alexis
    Chiarabini, Thibault
    Baylac, Pierre
    Valin, Nadia
    Urbina, Tomas
    Pacanowski, Jerome
    Mekinian, Arsene
    Brissot, Eolia
    M. 'Hammedi-Bouzina, Fella
    Lapusan, Simona
    Mohty, Mohamad
    Lacombe, Karine
    Ingiliz, Patrick
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1502 - 1505
  • [18] Disseminated gonococcal infection in a patient with paroxysmal nocturnal hemoglobinuria having received ravulizumab and meningococcal vaccine
    Yu, Zhi-Ye
    Tsai, Ming-Jui
    Lin, Yu-Jen
    Liu, Wang-Da
    Chou, Sheng-Chieh
    Hung, Chien-Ching
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (04) : 660 - 662
  • [19] FDA Approves Ravulizumab for Paroxysmal Nocturnal Hemoglobinuria
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (01) : 67 - 67
  • [20] Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment
    Kokoris, Styliani
    Polyviou, Antri
    Evangelidis, Paschalis
    Grouzi, Elisavet
    Valsami, Serena
    Tragiannidis, Konstantinos
    Gialeraki, Argyri
    Tsakiris, Dimitrios A.
    Gavriilaki, Eleni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
12345